Latest Articles
ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval - TradingView
ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval TradingView
Published: Feb. 27, 2026, 3:34 p.m.
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion - TradingView
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion TradingView
Published: Feb. 27, 2026, 2:50 p.m.
dtic Backs Probe into Sanitary Pad Safety Concerns - Devdiscourse
dtic Backs Probe into Sanitary Pad Safety Concerns Devdiscourse
Published: Feb. 27, 2026, 1:17 p.m.
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study - Cureus
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study Cureus
Published: Feb. 27, 2026, 7:22 a.m.
Probe into Sanitary Pad Brands Over Chemical Safety Concerns - Jacaranda FM
Probe into Sanitary Pad Brands Over Chemical Safety Concerns Jacaranda FM
Published: Feb. 25, 2026, 7:09 a.m.
UGA Forest Education Center to host annual fire safety festival in Guyton - WTOC
UGA Forest Education Center to host annual fire safety festival in Guyton WTOC
Published: Feb. 18, 2026, 4:34 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology
Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com
Published: Jan. 22, 2026, 4:02 p.m.
Terumo launches SurTract Safety Syringe in U.S. - Med-Tech Insights
Terumo launches SurTract Safety Syringe in U.S. Med-Tech Insights
Published: Jan. 6, 2026, 4:18 p.m.
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Dec. 22, 2025, 1:15 p.m.
Link copied to clipboard!